Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (431-440 of 568) with videos related to

Pageof 57
Sort By:
Trials|December 23, 2015
Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trialHo Kwong Li, Matthew Scarborough, Rhea Zambellas, et al.
Lancet (London, England)|July 6, 2004
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classesBruno Ledergerber, Jens D Lundgren, A Sarah Walker, et al.
Journal of Clinical Microbiology|January 30, 2015
Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) culturesAntonina A Votintseva, Louise J Pankhurst, Luke W Anson, et al.
Wellcome Open Research|September 2, 2024
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)Kathryn Maitland, Mainga Hamaluba, Nchafatso Obonyo, et al.
Critical Care (London, England)|November 29, 2019
Mortality risk over time after early fluid resuscitation in African childrenElizabeth C George, Sarah Kiguli, Peter Olupot Olupot, et al.
The Lancet. HIV|January 2, 2021
Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant dataJennifer M Ross, Anani Badje, Molebogeng X Rangaka, et al.
Vox Sanguinis|March 7, 2019
Haematological quality and age of donor blood issued for paediatric transfusion to four hospitals in sub-Saharan AfricaSophie Uyoga, Ayub Mpoya, Peter Olupot-Olupot, et al.
The Journal of Infectious Diseases|November 27, 2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus AbacavirNicaise Ndembi, Nicasie Ndembi, Ruth L Goodall, et al.
BMC Medicine|April 29, 2014
Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemiaPeter Olupot-Olupot, Charles Engoru, Jennifer Thompson, et al.
The Lancet. Infectious Diseases|October 21, 2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialVeronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, et al.
Pageof 57

Showing results (431-440 of 568) with videos related to

Sort By:
Pageof 57
Trials|December 23, 2015
Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trialHo Kwong Li, Matthew Scarborough, Rhea Zambellas, et al.
Lancet (London, England)|July 6, 2004
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classesBruno Ledergerber, Jens D Lundgren, A Sarah Walker, et al.
Journal of Clinical Microbiology|January 30, 2015
Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) culturesAntonina A Votintseva, Louise J Pankhurst, Luke W Anson, et al.
Wellcome Open Research|September 2, 2024
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)Kathryn Maitland, Mainga Hamaluba, Nchafatso Obonyo, et al.
Critical Care (London, England)|November 29, 2019
Mortality risk over time after early fluid resuscitation in African childrenElizabeth C George, Sarah Kiguli, Peter Olupot Olupot, et al.
The Lancet. HIV|January 2, 2021
Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant dataJennifer M Ross, Anani Badje, Molebogeng X Rangaka, et al.
Vox Sanguinis|March 7, 2019
Haematological quality and age of donor blood issued for paediatric transfusion to four hospitals in sub-Saharan AfricaSophie Uyoga, Ayub Mpoya, Peter Olupot-Olupot, et al.
The Journal of Infectious Diseases|November 27, 2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus AbacavirNicaise Ndembi, Nicasie Ndembi, Ruth L Goodall, et al.
BMC Medicine|April 29, 2014
Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemiaPeter Olupot-Olupot, Charles Engoru, Jennifer Thompson, et al.
The Lancet. Infectious Diseases|October 21, 2015
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trialVeronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, et al.
Pageof 57